Medique Diotame
Loading...Medique Diotame Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Liver warning: This product contains acetaminophen. Severe liver damage may occur if your child takes
- •
- more than 5 doses in 24 hours, which is the maximum daily amount
- •
- with other drugs containing acetaminophen
Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include:
- •
- skin reddening
- •
- blisters
- •
- rash
If a skin reaction occurs, stop use and seek medical help right away.
Sore throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.
- •
- with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
- •
- if your child has ever had an allergic reaction to this product or any of its ingredients
liver disease
taking the blood thinning drug warfarin
do not exceed recommended dose (see overdose warning)
- •
- pain gets worse or lasts more than 5 days
- •
- fever gets worse or lasts more than 3 days
- •
- new symptoms occur
- •
- redness or swelling is present
These could be signs of a serious condition.
Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical even if you do not notice any signs or symptoms.
- •
- with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
- •
- if your child has ever had an allergic reaction to this product or any of its ingredients
liver disease
Ask a doctor or pharmacist before use if your child istaking the blood thinning drug warfarin
Stop use and ask a doctor if- •
- pain gets worse or lasts more than 5 days
- •
- fever gets worse or lasts more than 3 days
- •
- new symptoms occur
- •
- redness or swelling is present
These could be signs of a serious condition.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
temporarily:
- •
- reduces fever
- •
- relieves minor aches and pains due to:
- •
- the common cold
- •
- flu
- •
- headache
- •
- sore throat
- •
- toothache
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Medique Diotame Manufacturers
-
Unifirst First Aid Corporation
![Medique Diotame (Bismuth Subsalicylate) Tablet, Chewable [Unifirst First Aid Corporation]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Medique Diotame | Walgreen Company
• this product does not contain directions or complete warnings for adult use • do not give more than directed (see overdose warning) • shake well before using • mL = milliliter; tsp = teaspoonful • find right dose on chart below. If possible, use weight to dose; otherwise, use age. • remove the child protective cap and squeeze your child’s dose into the dosing cup • repeat dose every 4 hours while symptoms last • do not give more than 5 times in 24 hoursWeight (lb)
Age (yr)
Dose (mL or tsp)*
under 24
under 2 years
ask a doctor
24-35
2-3 years
5 mL (1 tsp)
36-47
4-5 years
7.5 mL (1 ½ tsp)
48-59
6-8 years
10 mL (2 tsp)
60-71
9-10 years
12.5 mL (2 ½ tsp)
72-95
11 years
15 mL (3 tsp)
*or as directed by a doctor
Attention: use only enclosed dosing cup specifically designed for use with this product. Do not use any other dosing device.
-
Unique First Aid Corporation
Medique Diotame | E.r. Squibb & Sons, L.l.c.
2.1 Recommended DosageEVOTAZ is a fixed-dose combination product containing 300 mg of atazanavir and 150 mg of cobicistat. In treatment-naive and -experienced adults, the recommended dosage of EVOTAZ is one tablet taken once daily orally with food. Administer EVOTAZ in conjunction with other antiretroviral agents [see Drug Interactions (7)].
When coadministered with H2-receptor antagonists or proton-pump inhibitors, dose separation may be required [see Drug Interactions (7)].
2.2 Laboratory Testing Prior to Initiation of EVOTAZPrior to starting EVOTAZ, assess estimated creatinine clearance because cobicistat decreases estimated creatinine clearance due to inhibition of tubular secretion of creatinine without affecting actual renal glomerular function [see Warnings and Precautions (5.3)]. When coadministering EVOTAZ with tenofovir disoproxil fumarate (tenofovir DF) assess estimated creatinine clearance, urine glucose, and urine protein at baseline [see Warnings and Precautions 5.4].
2.3 Dosage in Patients with Renal ImpairmentEVOTAZ is not recommended in HIV-1 treatment-experienced patients with end-stage renal disease managed with hemodialysis [see Use in Specific Populations (8.6) and Clinical Pharmacology (12.3)].
EVOTAZ coadministered with tenofovir DF is not recommended in patients who have an estimated creatinine clearance below 70 mL/min [see Warnings and Precautions (5.4) and Adverse Reactions (6.1)].
2.4 Dosage in Patients with Hepatic ImpairmentEVOTAZ is not recommended in patients with hepatic impairment. [See Warnings and Precautions (5.6), Use in Specific Populations (8.7), and Clinical Pharmacology (12.3).]
![Medique Diotame (Bismuth Subsalicylate) Suspension [Unique First Aid Corporation]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=83db29d7-5d85-49d6-8cb6-740473365cf8&name=ataza-cobic-label.jpg)
Login To Your Free Account